Christine Mikail Cvijic, President and CFO at Neurogene Inc. (NGNE), sold 4,800 shares at $34.06 ($167K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Scheduled sale ($167k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.06 | 739 | $25K | 15.1% |
| 2 | $34.58 | 2,531 | $88K | 52.5% |
| 3 | $35.23 | 1,530 | $54K | 32.4% |
| Total | $34.71 avg | 4,800 | $167K | 100% |
| Filing → |
| NGNE | SELL | 2026-03-30 | $111K | — | Filing → |
| NGNE | SELL | 2026-03-17 | $168K | — | Filing → |
| NGNE | SELL | 2026-03-03 | $121K | — | Filing → |